![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, May 26, 2023 11:15:12 AM
https://www.otcmarkets.com/otcapi/company/financial-report/371665/content
B. List any subsidiaries, parent company, or affiliated companies.
The Company is a 49% owner of the Bulgarian entity IMMB BG, which held a sub-license agreement issued
by ENZC for the proprietary immunotherapy treatment until it was terminated in the second quarter of 2021
and the investment written off as worthless in the yearend 2021 financials.
The Company is 100% owner of Biogenysis,
Inc. The Company is 100% owner of
Virogentics, Inc. The Company is 100%
owner of RobustoMed, Inc.
The Company is 100% owner of BioClonetics Immunotherapy, Inc.
The Company is 50% owner of International Medical Partners Ltd a Bulgarian entity
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM